Abstract: The present disclosure relates to the use of an NK1 antagonist prodrug compound and a 5-HT3 receptor antagonist. In particular, the present disclosure relates to the use of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in combination with a 5-HT3 receptor antagonist in the preparation of a drug for preventing or treating nausea and/or vomiting.

Abstract: A request to perform a memory access operation on a plurality of memory cells of a memory device is received. In response to determining that the request is from a host, a first error recovery operation is performed, wherein the first error recovery operation is associated with a first plurality of demarcation voltages. In response to determining that the request is from a controller, a second error recovery operation is performed, wherein the second error recovery operation is associated with a second plurality of demarcation voltages, wherein the second plurality of demarcation voltages comprises a greater number of demarcation voltages than the first plurality of demarcation voltages.

Abstract: A sectional type card feeding mechanism and method. The mechanism includes: a rear section mechanism including a rear section frame and a rear section belt, the rear section belt being movably connected to the rear section frame in a lengthwise direction of the rear section frame to convey cards; and a front section mechanism including a front section frame which is connected to an end of the rear section frame, the rear section belt driving the cards to be transferred to the front section frame to be discharged. The process of card feeding is divided into two sections. Cards are placed on the rear section belt of the rear section mechanism, and after the rear section belt conveys the cards to one end of the front section frame, the cards are sent to the other end of the front section frame to be discharged.

Abstract: Disclosed is a stator structure of a flat wire motor, including a stator core, a first conductor, a second conductor and a third conductor. An inner wall of the stator core is provided circumferentially and uniformly with m stator slots; the first conductor, the second conductor and the third conductor are provided in the stator slots. The present application uses a 2-way N-layer winding solution to provide a flat wire winding connection solution with balanced three-phase resistance and no loop current by connecting six neutral point conductors, a first conductor, six second conductors and six third conductors; the three-phase outlet wire conductors and neutral point copper row are in two adjacent layers, and positions are concentrated after twisting the head to simplify the end structure.

Abstract: A request to perform a memory access operation on a plurality of memory cells of a memory device is receive. A request type associated with the memory access operation is determined. In response to determining that the request type associated with the request type associated with the memory access operation is a first request type, an error recovery operation associated with the first request type is performed. In response to determining that the request type associated with the memory access operation is a second request type, an error recovery operation associated with the second request type is performed.

Abstract: The disclosure provides a decolorization and purification method of BHET material, which includes the following steps. A first dose of activated carbon is added to preliminarily treat the BHET material. After the preliminary treatment, a first cooling crystallization process and filtration are performed to obtain BHET crystals. Afterwards, an oxidant is used to chemically react with the BHET crystals to destroy a dye or impurities, and then a second dose of activated carbon is added to adsorb a chemically reacted oxide. Next, a second cooling crystallization process, filtration, and drying are performed to obtain a finished product of BHET.

Abstract: Provided are an anti-CD79B antibody-drug conjugate, and a preparation method therefor and pharmaceutical use thereof. In particular, provided are an antibody-drug conjugate (ADC) which comprises an anti-CD79B antibody conjugated with an MMAE or a derivative thereof, exatecan or a derivative thereof, or Eribulin or a derivative thereof, a pharmaceutical composition containing the ADC, and use thereof in preparation of a drug for treatment of a CD79B-mediated disease or disorder, especially use thereof in preparation of an anti-cancer drug.

Abstract: A method for manufacturing polyester polyhydric alcohol is provided. The method for manufacturing the polyester polyhydric alcohol includes steps as follows. A polybasic acid and a first polyhydric alcohol are mixed for a first oligomerization reaction, so as to form a first oligomer mixture. A second polyhydric alcohol is added into the first oligomer mixture for a second oligomerization reaction when a remaining amount of the first polyhydric alcohol in the first oligomer mixture is lower than or equal to 1 mol %, so as to form a second oligomer mixture. A catalyst is added into the second oligomer mixture for a polycondensation reaction, so as to obtain a polyester polyhydric alcohol product. The polyester polyhydric alcohol product has an Alpha value of lower than 30.

Abstract: An example system can include a memory component and a processing device. The memory component can include a group of memory cells. The processing device can be coupled to the memory component. The processing device can be configured to use a first voltage window for a set of memory cells of the group of memory cells during a first time period. The processing device can be configured to determine that an error rate of a sub-set of the set of memory cells is above a threshold error rate. The processing device can be configured to, in response to the determination that the error rate of the sub-set of memory cells is above the threshold error rate, use a second voltage window for the set of memory cells of the group of memory cells during a second time period.

Abstract: A method includes determining, for a plurality of memory dice, binning information relating to quality characteristics of each of the plurality of memory dice. The method further includes performing a select gate scan to determine a first threshold voltage and a first threshold voltage window of each of the plurality of memory dice, and, based on the determined quality characteristics of each of the plurality of memory dice, perform an erase and program operation to set a second threshold voltage with a second threshold voltage window of a subset of memory dice among the plurality of memory dice where the second threshold voltage window is greater than the first threshold voltage window.

Abstract: The present disclosure discloses an endoscope adapter and an auxiliary instrument for endoscopic surgery. The endoscope adapter includes an inner sleeve and an outer sleeve. The inner sleeve includes an inner channel configured for accommodating a distal end of an insertion portion of the endoscope. The outer sleeve is sleeved on the inner sleeve, and capable of defining an outer channel between the outer sleeve and the inner sleeve, and the outer channel is configured for accommodating and providing a space for pushing and drawing a robot arm assembly having an end effector.

Abstract: The present invention relates to a sulfonylurea derivative and medical uses thereof, specifically relating to the sulfonylurea derivative shown in general formula (I), a preparation method thereof, a pharmaceutical composition containing same, and a use of same for treating diseases and disorders affected by neuronal damage, for example: cerebral stroke, brain damage, neuropathic pain, migraines, inflammatory pain, chronic pain, or depression. The definition of each group in the general formula (I) is the same as that in the description.

Abstract: A graphics processing unit (GPU) sequences provision of operands to a set of operand registers, thereby allowing the GPU to share at least one of the operand registers between processing. The GPU includes a plurality of arithmetic logic units (ALUs) with at least one of the ALUs configured to perform double precision operations. The GPU further includes a set of operand registers configured to store single precision operands. For a plurality of executing threads that request double precision operations, the GPU stores the corresponding operands at the operand registers. Over a plurality of execution cycles, the GPU sequences transfer of operands from the set of operand registers to a designated double precision operand register. During each execution cycle, the double-precision ALU executes a double precision operation using the operand stored at the double precision operand register.

Abstract: The present disclosure concerns methods of using novel bacterial strains of 0617-T307, 0917-T305, 0917-T306, 0917-T307, 0118-T319, 0318-T327, and 0418-T328, the cell broth and novel metabolites produced from the bacterial strains, to inhibit the growth of a variety of microbial species for bacterial pathogens that cause citrus Huanglongbing (citrus greening disease), Zebra chip (ZC) disease of potato, tomato, and other plants of the family Solanaceae and plants of the family Apiaceae and Umbelliferae.

Abstract: The present invention discloses a dyeable 1.74 resin lens and a preparation method thereof. The resin lens includes a module layer with a refractive index being 1.74, a dyeable layer with a refractive index being 1.60 is poured on an upper surface of the module layer, an upward curved degree of the dyeable layer is the same as an upward curved degree of the module layer, and a center thickness of the dyeable layer is 0.5-1.2 mm. According to the dyeable 1.74 resin lens of the present invention, a layer of dyeable 1.60plus resin lens is attached to a surface of a 1.74 lens, dyeing performance is good, a visible light transmittance can reach 10-30%, and the blank that the 1.74 lens cannot be dyed is filled.

Abstract: A helmet (10) comprises an outer shell (12), an inner lining (14), and at least one releasable connector arrangement adapted to enable the outer shell (12) to be removably attached to the inner lining (14). The releasable connector arrangement includes a connecting stem (28) on the outer shell (12), and a receiving channel (30) in the inner lining (14).

Abstract: A data storage device includes a nonvolatile memory device, a volatile memory device, a data encryption circuit configured to encrypt data outputted from the nonvolatile memory device, a data decryption circuit configured to decrypt encrypted data output from the data encryption circuit and configured to provide the decrypted data to the volatile memory device, and a processor configured to perform a first process that controls installation of a first in-storage program in the data storage device, a second process configured to manage a mapping table storing a relation between a logical address and a physical address of the nonvolatile memory device, and a third process configured to execute the first in-storage program.

Abstract: A processing unit such as a graphics processing unit (GPU) includes a plurality of vector signal processors (VSPs) that include multiply/accumulate elements. The processing unit also includes a plurality of registers associated with the plurality of VSPs. First portions of first and second matrices are fetched into the plurality of registers prior to a first round that includes a plurality of iterations. The multiply/accumulate elements perform matrix multiplication and accumulation on different combinations of subsets of the first portions of the first and second matrices in the plurality of iterations prior to fetching second portions of the first and second matrices into the plurality of registers for a second round. The accumulated results of multiplying the first portions of the first and second matrices are written into an output buffer in response to completing the plurality of iterations.

Abstract: The present invention relates to an antimicrobial composition and probiotics against bacterial and fungal pathogens of fish. In particular, the invention pertains to a novel strain of the bacterial species Pseudomonas chlororaphis subsp. aurantiaca 1214-CHY4 (ATCC accession number PTA-126941), the cells, cell broth, and novel metabolites produced from the bacterial strain that can inhibit the growth of a variety of fish pathogens.